1. Home
  2. AVDL vs WGO Comparison

AVDL vs WGO Comparison

Compare AVDL & WGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVDL
  • WGO
  • Stock Information
  • Founded
  • AVDL 2015
  • WGO 1958
  • Country
  • AVDL Ireland
  • WGO United States
  • Employees
  • AVDL N/A
  • WGO N/A
  • Industry
  • AVDL Biotechnology: Pharmaceutical Preparations
  • WGO Homebuilding
  • Sector
  • AVDL Health Care
  • WGO Industrials
  • Exchange
  • AVDL Nasdaq
  • WGO Nasdaq
  • Market Cap
  • AVDL 861.4M
  • WGO 883.8M
  • IPO Year
  • AVDL 1996
  • WGO N/A
  • Fundamental
  • Price
  • AVDL $10.04
  • WGO $32.41
  • Analyst Decision
  • AVDL Strong Buy
  • WGO Buy
  • Analyst Count
  • AVDL 6
  • WGO 11
  • Target Price
  • AVDL $18.17
  • WGO $39.30
  • AVG Volume (30 Days)
  • AVDL 1.6M
  • WGO 807.2K
  • Earning Date
  • AVDL 08-07-2025
  • WGO 06-25-2025
  • Dividend Yield
  • AVDL N/A
  • WGO 4.15%
  • EPS Growth
  • AVDL N/A
  • WGO N/A
  • EPS
  • AVDL N/A
  • WGO N/A
  • Revenue
  • AVDL $194,450,000.00
  • WGO $2,741,800,000.00
  • Revenue This Year
  • AVDL $56.88
  • WGO N/A
  • Revenue Next Year
  • AVDL $29.81
  • WGO $5.77
  • P/E Ratio
  • AVDL N/A
  • WGO N/A
  • Revenue Growth
  • AVDL 252.64
  • WGO N/A
  • 52 Week Low
  • AVDL $6.38
  • WGO $28.00
  • 52 Week High
  • AVDL $17.30
  • WGO $65.65
  • Technical
  • Relative Strength Index (RSI)
  • AVDL 63.41
  • WGO 52.15
  • Support Level
  • AVDL $8.74
  • WGO $30.30
  • Resistance Level
  • AVDL $9.56
  • WGO $33.67
  • Average True Range (ATR)
  • AVDL 0.40
  • WGO 1.28
  • MACD
  • AVDL 0.08
  • WGO 0.41
  • Stochastic Oscillator
  • AVDL 98.70
  • WGO 77.78

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

About WGO Winnebago Industries Inc.

Winnebago Industries manufactures Class A, B, and C motor homes along with towables, customized specialty vehicles, boats, and parts. Headquartered in Eden Prairie, Minnesota, Winnebago has been producing recreational vehicles since 1958. Revenue was nearly $3 billion in fiscal 2024. Winnebago expanded into towables in 2011 with the acquisition of SunnyBrook and acquired Grand Design in November 2016. Towables made up 83% of the firm's RV unit volume, up from 31% in fiscal 2016. The company's total RV unit volume was 38,796 in fiscal 2024. Winnebago expanded into boating in 2018 with the purchase of Chris-Craft, bought premium motor home maker Newmar in November 2019, and bought Barletta pontoon boats in August 2021. It also is developing electric and autonomous technology.

Share on Social Networks: